Welcome to CDC stacks | HIV prevalence and risk behaviors among people who inject drugs in Songkhla, Thailand: A respondent-driven sampling survey☆ - 40336 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
HIV prevalence and risk behaviors among people who inject drugs in Songkhla, Thailand: A respondent-driven sampling survey☆
Filetype[PDF-348.64 KB]


No Related Documents.
You May Also Like:
  1. Diverse HIV epidemics among people who inject drugs in Thailand: Evidence from respondent-driven sampling surveys in Bangkok and Chiang Mai☆
    Personal Author:
    Prybylski, Dimitri; Manopaiboon, Chomnad; Visavakum, Prin; Yongvanitjit, Kovit; Aramrattana, Apinun; Manomaipiboon, Parnrudee; Tanpradech, Suvimon; Suksripanich, Orapin; Pattanasin, Sarika; Wolfe, Mitchell; Whitehead, Sara J.;
    Published:
    Jan 12 2015
    Source:
    Drug Alcohol Depend. 148:126-135.
    Description:
    Background : Thailand’s long-standing HIV sero-sentinel surveillance system for people who inject drugs (PWID) is confined to those in methadone-based drug treatment clinics and representative data are scarce, especially outside of Bangkok. : Metho...
    File Type:
    Filetype[PDF - 686.57 KB]
  2. HIV and STI Prevalence and Injection Behaviors Among People Who Inject Drugs in Nairobi: Results from a 2011 Bio-behavioral Study Using Respondent-Driven Sampling
    Personal Author:
    Tun, Waimar; Sheehy, Meredith; Broz, Dita; Okal, Jerry; Muraguri, Nicholas; Raymond, H. Fisher; Musyoki, Helgar; Kim, Andrea A.; Muthui, Mercy; Geibel, Scott;
    Published:
    Feb 2015
    Source:
    AIDS Behav. 19(Suppl 1):24-35.
    Series:
    PEPFAR
    Description:
    There is a dearth of evidence on injection drug use and associated HIV infections in Kenya. To generate population-based estimates of characteristics and HIV/STI prevalence among people who inject drugs (PWID) in Nairobi, a cross-sectional study was ...
    File Type:
    Filetype[PDF - 364.37 KB]
  3. Lessons learned from respondent-driven sampling recruitment in Nairobi: experiences from the field
    Personal Author:
    Okal, Jerry; Raymond, Henry F.; Tun, Waimar; Musyoki, Helgar; Dadabhai, Sufia; Broz, Dita; Nyamu, Joan; Kuria, David; Muraguri, Nicholas; Geibel, Scott;
    Published:
    Mar 11 2016
    Source:
    BMC Res Notes. 9.
    Series:
    PEPFAR
    Description:
    Background : Respondent-driven sampling (RDS) is used in a variety of settings to study hard-to-reach populations at risk for HIV and sexually transmitted infections. However, practices leading to successful recruitment among diverse populations in l...
    File Type:
    Filetype[PDF - 4.35 MB]
  4. Enrollment Characteristics and Risk Behaviors of Injection Drug Users Participating in the Bangkok Tenofovir Study, Thailand
    Personal Author:
    Martin, Michael.; Vanichseni, Suphak.; Suntharasamai, Pravan.; Sangkum, Udomsak.; Chuachoowong, Rutt.; Mock, Philip A.; Leethochawalit, Manoj.; Chiamwongpaet, Sithisat.; Kittimunkong, Somyot.; van Griensven, Frits.; McNicholl, Janet M.; Paxton, Lynn.; Choopanya, Kachit.;
    Corporate Author:
    for the Bangkok Tenofovir Study Group
    Published:
    Sep 28 2011
    Source:
    PLoS One. 2011; 6(9).
    Description:
    Background : The Bangkok Tenofovir Study was launched in 2005 to determine if pre-exposure prophylaxis with tenofovir will reduce the risk of HIV infection among injecting drug users (IDUs). We describe recruitment, screening, enrollment, and baselin...
    File Type:
    Filetype[PDF - 155.39 KB]
  5. HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs — 20 Cities, United States, 2012
    Personal Author:
    Spiller, Michael W.; Broz, Dita; Wejnert, Cyprian; Nerlander, Lina; Paz-Bailey, Gabriela;
    Published:
    Mar 20 2015
    Source:
    MMWR Morb Mortal Wkly Rep. 2015; 64(10):270-275.
    Description:
    In the United States, an estimated 7% of new diagnoses of human immunodeficiency virus (HIV) infection in 2012 were attributed to injection drug use, and an additional 3% to male-to-male sexual contact and injection drug use. To monitor HIV prevalenc...
    File Type:
    Filetype[PDF - 309.65 KB]